Results
Revise Search
-
Filters:
- "BR2019-05" OR "PD19-02" OR "PD19-01" OR "BR2018-15" OR "BR2018-13" OR "BR2018-04" OR "PD18-01" OR "GC17-06" OR "BR2017-05" OR "BR2017-15" OR "GC16-30" OR "BR2016-04" OR "PD15-06" OR "BR2015-02" OR "GC14-55" OR "BR2014-12" OR "BR2014-04" OR "BR2014-03" OR "BR2014-02" OR "GC12-72"
- 2017
- 2016
- Health care and patient safety
- Health human resources
- Policy resolution
Opioid overdose prevention supplies available in publicly accessible locations
https://policybase.cma.ca/en/permalink/policy13703
- Date
- 2017-08-23
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
- Policy Type
- Policy resolution
- Date
- 2017-08-23
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
- Text
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Canadian guideline for safe and effective use of opioids for chronic pain
https://policybase.cma.ca/en/permalink/policy11901
- Date
- 2016-08-24
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC16-30
- The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
- Policy Type
- Policy resolution
- Date
- 2016-08-24
- Resolution
- GC16-30
- The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
- Text
- The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.